‌

US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies

Patent 11753479 was granted and assigned to Kymab on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Steve Holmes

Ian Kirby

Miha Kosmac

Jamie Campbell

Date of Patent

September 12, 2023

Patent Application Number

17115021

Date Filed

December 8, 2020

Patent Citations

US Patent 7196175 Antibodies to JTT-1 protein and cells secreting such antibodies

US Patent 7226909 Methods of inhibiting transmission of a costimulatory signal of lymphocytes

US Patent 7259247 Anti-human T-cell costimulating polypeptide monoclonal antibodies

US Patent 7261893 Neutralizing antibodies against GDF-8 and uses therefor

US Patent 7279560 Antibody fragments to JTT-1 protein and cells secreting such antibody fragments

US Patent 7291331 Methods of treating OX40 medicated recall immune responses

US Patent 7300754 Methods for detecting the presence of or predisposition to autosomal dominant hypercholesterolemia

US Patent 7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules

...

Patent Primary Examiner

Maher M. Haddad

The present invention relates to anti-human OX40L antibodies, new medical uses and methods.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.